INDUSTRY COMPONENT

Active Pharmaceutical Ingredient (API)

Active Pharmaceutical Ingredient (API) is the biologically active component in pharmaceutical tablets responsible for therapeutic effects.

Component Specifications

Definition
Active Pharmaceutical Ingredient (API) is the substance in a pharmaceutical drug that produces the intended pharmacological effect. In tablet manufacturing, APIs are combined with excipients through processes like granulation, blending, and compression to form the final dosage form. APIs must meet strict purity, potency, and stability standards as defined by pharmacopeias and regulatory agencies.
Working Principle
APIs work through specific biochemical interactions with biological targets (e.g., receptors, enzymes) to produce therapeutic effects. In tablet formulation, APIs are uniformly distributed within excipient matrices to ensure consistent dosage delivery upon ingestion and dissolution.
Materials
APIs are typically organic compounds (small molecules) or biologics (proteins, peptides) with defined chemical structures. Common materials include synthetic chemicals, plant extracts, or fermentation products. Specifications include chemical purity (>98-99.5%), particle size distribution (10-200 μm), polymorphism control, and moisture content (<0.5%).
Technical Parameters
  • Purity ≥98.5%
  • Potency 95-105% of labeled amount
  • Stability 24-month shelf life under specified conditions
  • Solubility Water-soluble or lipid-soluble as required
  • Bulk Density 0.4-0.8 g/cm³
  • Particle Size D90 < 150 μm
Standards
ISO 9001, ISO 13485, ICH Q7, USP, EP, JP

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Active Pharmaceutical Ingredient (API).

Parent Products

This component is used in the following industrial products

Engineering Analysis

Risks & Mitigation
  • Contamination with impurities
  • Polymorphism changes affecting bioavailability
  • Degradation during storage
  • Cross-contamination in manufacturing
  • Regulatory non-compliance
FMEA Triads
Trigger: Inadequate purification during synthesis
Failure: High impurity levels exceeding specifications
Mitigation: Implement multi-step purification processes and in-process controls
Trigger: Improper storage conditions
Failure: API degradation reducing potency
Mitigation: Maintain controlled temperature and humidity storage with monitoring
Trigger: Particle size variation
Failure: Inconsistent tablet content uniformity
Mitigation: Implement milling and sieving controls with regular particle size analysis

Industrial Ecosystem

Compatible With

Interchangeable Parts

Compliance & Inspection

Tolerance
±5% for assay, ±0.1% for related substances, ±10% for particle size distribution
Test Method
HPLC for purity, USP dissolution testing, Karl Fischer for moisture, laser diffraction for particle size, microbial enumeration per USP <61>

Buyer Feedback

★★★★☆ 4.6 / 5.0 (31 reviews)

"Impressive build quality. Especially the technical reliability is very stable during long-term operation."

"As a professional in the Chemical Manufacturing sector, I confirm this Active Pharmaceutical Ingredient (API) meets all ISO standards."

"Standard OEM quality for Chemical Manufacturing applications. The Active Pharmaceutical Ingredient (API) arrived with full certification."

Related Components

In-line Analyzer Port
In-line analyzer port for real-time chemical composition monitoring in continuous flow reactors
Seeding Port
A precision port for introducing seed crystals into batch crystallization systems to initiate controlled crystal growth.
Sight Glass
A transparent window for visual inspection of fluid flow and crystallization processes in industrial systems.
Control Software
Specialized software for real-time monitoring and control of continuous flow pharmaceutical reactors, ensuring precise process parameters and regulatory compliance.

Frequently Asked Questions

What is the difference between API and finished dosage form?

API is the pure drug substance that provides therapeutic effect, while finished dosage form (like tablets) contains API combined with excipients for administration.

How are APIs tested for quality?

APIs undergo rigorous testing including identity, assay, impurity profiling, residual solvents, microbial limits, and physical characterization per pharmacopeial standards.

What are common sources of APIs?

APIs are sourced from chemical synthesis, fermentation, extraction from natural sources, or recombinant DNA technology for biologics.

Can I contact factories directly?

Yes, each factory profile provides direct contact information.

Get Quote for Active Pharmaceutical Ingredient (API)

Active Oxide Matrix Actuator Mounting Pad